U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734194) titled 'Remimazolam-Fentanyl Mild Conscious Sedation Regimen in Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation' on July 24.
Brief Summary: This prospective single-arm study will evaluate whether mild conscious sedation using remimazolam with fentanyl is a feasible alternative to deeper sedation or general anaesthesia during FARAPULSETM pulsed-field ablation for paroxysmal atrial fibrillation, with careful periprocedural monitoring and assessment of both sedation-related safety outcomes and patient-reported procedural experience.
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
Atrial Fibrillation (AF)
Recruitmen...